Squarepoint Ops LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$150,195
-21.0%
14,582
-48.2%
0.00%
-100.0%
Q2 2021$190,000
+75.9%
28,162
+135.3%
0.00%0.0%
Q1 2021$108,000
-71.5%
11,968
-78.9%
0.00%
-66.7%
Q4 2020$379,000
+23.1%
56,666
-7.4%
0.00%
-25.0%
Q3 2020$308,00061,1650.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 4,133,464$45,592,0005.54%
Stonepine Capital Management, LLC 747,863$8,249,0004.45%
JW Asset Management, LLC 444,439$4,902,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$40,320,0002.15%
ARMISTICE CAPITAL, LLC 1,150,000$12,685,0001.62%
FALCON POINT CAPITAL, LLC 855,101$9,432,0001.27%
Perceptive Advisors 1,429,114$15,763,0000.79%
KNOTT DAVID M 126,463$1,395,0000.58%
HEARTLAND ADVISORS INC 700,000$7,721,0000.50%
Sio Capital Management, LLC 91,413$1,008,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders